Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Jerusalem Daily Journal.
Press releases published on June 3, 2025

New Collaboration Between Psifas and OpenDNA: Predicting Common Diseases Through AI and Genomic Data
HAIFA, ISRAEL, ISRAEL, June 3, 2025 /EINPresswire.com/ -- The Israeli National Initiative for Personalized Medicine, Psifas, and OpenDNA a Genomic AI biotech company have announced a strategic collaboration to develop artificial intelligence models that …

From Conflict to Compassion: Divided Homeland Inspires Author to Build Bridges Through Stories of Love
Michael Weiss feels called to inspire, uplift and connect readers through captivating stories of the human experience that transcend borders. NEW YORK, NY, UNITED STATES, June 3, 2025 /EINPresswire.com/ -- Jerusalem-born author and entrepreneur Michael …

Teva Announces Pricing and Early Acceptance Results of its Debt Tender Offer
TEL AVIV, Israel, June 03, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) (“Teva”) announced today the pricing and early acceptance results of its previously announced tender offers (the “Offers”) to purchase for cash …

InspireMD Announces Appointment of Michael Lawless as Chief Financial Officer
MIAMI, June 03, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Prime carotid stent system for the treatment of carotid artery disease and prevention of stroke, today announced the appointment of Michael Lawless, an …

Nayax to Present at the William Blair Growth Conference in Chicago on June 4, 2025
HERZLIYA, Israel, June 03, 2025 (GLOBE NEWSWIRE) -- Nayax Ltd. (Nasdaq: NYAX; TASE: NYAX), a global commerce enablement and payments platform designed to help merchants scale their business by simplifying payments and maximizing loyalty, today announced …

Nanox to Participate in Sidoti Small Cap Conference
PETACH TIKVA, Israel, June 03, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, today announced that it will participate in the Sidoti Small Cap Conference to be held …

Enlight Secures Financing for Spain’s Largest Hybrid Renewable Energy Project
Enlight expands its successful Gecama Wind Project, transforming it into the largest hybrid power complex of its kind in Spain The project combines wind, solar, and utility-scale battery storage to deliver clean electricity around the clock The hybrid …

Rail Vision Secures $335,000 Follow-On Order from Major Latin American Mining Company After Successful Trial
The order marks a significant commercial milestone and signals Rail Vision’s continued expansion in the Latin American market Ra’anana, Israel, June 03, 2025 (GLOBE NEWSWIRE) -- Rail Vision Ltd. (Nasdaq: RVSN), a leader in railway safety and AI-driven …

Teva Announces Early Tender Results of its Debt Tender Offer, Increase to Tender Pool Caps and Total Maximum Amount and Election of Early Settlement
TEL AVIV, Israel, June 03, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) (“Teva”) announced today the early tender results in connection with its previously announced tender offers (the “Offers”) as specified below for …

Gilat Signs a $40 Million Contract for Virtualized SkyEdge IV Platform
PETAH TIKVA, Israel, June 03, 2025 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (NASDAQ: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions and services, announced today that it has received a $40 million contract for …

Tower Semiconductor to Present at IMS 2025 Highlighting Recent Innovations in RF Foundry Technology
Presenting a joint white paper with pSemi nominated for Best Industry Paper Award highlighting next-generation RF switch technology MIGDAL HAEMEK, Israel, June 3, 2025 – Tower Semiconductor (NASDAQ/TASE: TSEM), a leading foundry of high-value analog …

Kamari Pharma Announces Closing of $23 Million Financing to Advance its First-In-Class Oral TRPV3 Inhibitor for Rare Genetic Skin Diseases
Financing co-led by new investor BRM Group and existing investor Pontifax Lead program KM023 is a first-in-class oral TRPV3 inhibitor entering clinical development for the treatment of three rare genetic skin diseases; Olmsted syndrome, severe keratoderma …